Table 1 Population characteristics
Patient characteristics | Number (%) [N = 61] |
Male | 25 (40.9%) |
Female | 36 (59.1%) |
PET scanner 1 (GE Discovery ST-4) | 20 (32.8%) |
PET scanner 2 (GE Discovery ST-16) | 21 (34.4%) |
PET scanner 3 (GE Discovery IQ) | 20 (32.8%) |
Tumor characteristics | |
Rectal-colon cancer | 13 (21.3%) |
Lung cancer | 13 (21.3%) |
Hodgkin/non-Hodgkin lymphoma | 9 (14.8%) |
Gynecological cancer | 8 (13.1%) |
Breast cancer | 8 (13.1%) |
Melanoma | 4 (6.6%) |
Pancreatic cancer | 2 (3.3%) |
Gastric cancer | 2 (3.3%) |
Cholangiocarcinoma | 1 (1.6%) |
Head and neck cancer | 1 (1.6%) |
Median (range) | |
Age | 66 years (33-84) |
Body weight | 67 kg (40-100) |
Dose injected (study protocol) | 131 MBq (99-199) |
Reference dose (standard procedure)a | 196 MBq (148-296) |